Literature DB >> 19336744

R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: influence of prior autologous stem-cell transplantation on outcome.

Alejandro Martín, María-Dolores Caballero.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19336744      PMCID: PMC2675691          DOI: 10.3324/haematol.2009.006452

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  2 in total

Review 1.  Salvage therapy for relapsed or refractory diffuse large B-cell lymphoma: impact of prior rituximab.

Authors:  Rohit Sud; Jonathan W Friedberg
Journal:  Haematologica       Date:  2008-12       Impact factor: 9.941

2.  R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.

Authors:  Alejandro Martín; Eulogio Conde; Montserrat Arnan; Miguel A Canales; Guillermo Deben; Juan M Sancho; Rafael Andreu; Antonio Salar; Pedro García-Sanchez; Lourdes Vázquez; Sara Nistal; María-José Requena; Eva M Donato; José A González; Angel León; Concepción Ruiz; Carlos Grande; Eva González-Barca; María-Dolores Caballero
Journal:  Haematologica       Date:  2008-10-22       Impact factor: 9.941

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.